BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 25190124)

  • 1. Level 7 disease does not confer worse outcome than level 6 disease in differentiated thyroid cancer.
    Wang LY; Palmer FL; Thomas D; Nixon IJ; Tuttle RM; Shah JP; Patel SG; Shaha AR; Ganly I
    Ann Surg Oncol; 2015 Feb; 22(2):441-5. PubMed ID: 25190124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central lymph node characteristics predictive of outcome in patients with differentiated thyroid cancer.
    Wang LY; Palmer FL; Nixon IJ; Thomas D; Shah JP; Patel SG; Tuttle RM; Shaha AR; Ganly I
    Thyroid; 2014 Dec; 24(12):1790-5. PubMed ID: 25268855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Implication of N1b Classification in the Eighth Edition of the Tumor-Node-Metastasis Staging System of Differentiated Thyroid Cancer.
    Kim M; Jeon MJ; Oh HS; Park S; Song DE; Sung TY; Kim TY; Chung KW; Kim WB; Shong YK; Lee YM; Kim WG
    Thyroid; 2018 Apr; 28(4):496-503. PubMed ID: 29620964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparable outcomes for patients with pT1a and pT1b differentiated thyroid cancer: Is there a need for change in the AJCC classification system?
    Wang LY; Nixon IJ; Palmer FL; Thomas D; Tuttle RM; Shaha AR; Patel SG; Shah JP; Ganly I
    Surgery; 2014 Dec; 156(6):1484-9; discussion 1489-90. PubMed ID: 25456937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management and outcome of recurrent well-differentiated thyroid carcinoma.
    Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using the American Thyroid Association Risk-Stratification System to Refine and Individualize the American Joint Committee on Cancer Eighth Edition Disease-Specific Survival Estimates in Differentiated Thyroid Cancer.
    Ghaznavi SA; Ganly I; Shaha AR; English C; Wills J; Tuttle RM
    Thyroid; 2018 Oct; 28(10):1293-1300. PubMed ID: 29897011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of distribution of nodal disease in differentiated thyroid cancers in an oncosurgical center in Sri Lanka.
    Amarasinghe IY; Perera NM; Bahinathan N; Marzook HH; Peiris AK
    Ann Surg Oncol; 2007 May; 14(5):1560-4. PubMed ID: 17318279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck.
    Lee CW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Ann Surg Oncol; 2015 Jan; 22(1):117-24. PubMed ID: 25034816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition.
    Chow SM; Yau S; Kwan CK; Poon PC; Law SC
    Endocr Relat Cancer; 2006 Dec; 13(4):1159-72. PubMed ID: 17158761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Seventh and Eighth Editions of the American Joint Committee on Cancer/Union for International Cancer Control Tumor-Node-Metastasis Staging System for Differentiated Thyroid Cancer.
    Kim M; Kim WG; Oh HS; Park S; Kwon H; Song DE; Kim TY; Shong YK; Kim WB; Sung TY; Jeon MJ
    Thyroid; 2017 Sep; 27(9):1149-1155. PubMed ID: 28635571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective lateral compartment neck dissection for thyroid cancer.
    Welch K; McHenry CR
    J Surg Res; 2013 Sep; 184(1):193-9. PubMed ID: 23816244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Life expectancy is reduced in differentiated thyroid cancer patients ≥ 45 years old with extensive local tumor invasion, lateral lymph node, or distant metastases at diagnosis and normal in all other DTC patients.
    Verburg FA; Mäder U; Tanase K; Thies ED; Diessl S; Buck AK; Luster M; Reiners C
    J Clin Endocrinol Metab; 2013 Jan; 98(1):172-80. PubMed ID: 23150687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restaging of differentiated thyroid carcinoma by the sixth edition AJCC/UICC TNM staging system: stage migration and predictability.
    Lang B; Lo CY; Chan WF; Lam KY; Wan KY
    Ann Surg Oncol; 2007 May; 14(5):1551-9. PubMed ID: 17318278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes in older or younger patients with papillary thyroid carcinoma: impact of lymphadenopathy and patient age.
    Wada N; Masudo K; Nakayama H; Suganuma N; Matsuzu K; Hirakawa S; Rino Y; Masuda M; Imada T
    Eur J Surg Oncol; 2008 Feb; 34(2):202-7. PubMed ID: 18023321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
    Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
    G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendation for subclass evaluation of TNM stage iva papillary thyroid carcinomas: T4aN1b patients are at risk for recurrence and survival.
    Wada N; Masudo K; Nakayama H; Suganuma N; Matsuzu K; Hirakawa S; Rino Y; Masuda M; Imada T
    Ann Surg Oncol; 2008 May; 15(5):1511-7. PubMed ID: 18299932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic variables and calcitonin in medullary thyroid cancer.
    Clark JR; Fridman TR; Odell MJ; Brierley J; Walfish PG; Freeman JL
    Laryngoscope; 2005 Aug; 115(8):1445-50. PubMed ID: 16094121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes in patients with poorly differentiated thyroid carcinoma.
    Ibrahimpasic T; Ghossein R; Carlson DL; Nixon I; Palmer FL; Shaha AR; Patel SG; Tuttle RM; Shah JP; Ganly I
    J Clin Endocrinol Metab; 2014 Apr; 99(4):1245-52. PubMed ID: 24512493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.